GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today ...
Zacks Investment Research on MSN
Coherus Oncology (CHRS) reports Q4 loss, misses revenue estimates
Coherus Oncology (CHRS) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to a loss of $0.28 per share a year ago. These figures ...
Dr Simon Feldhaus, the chief medical officer of The Balance Rehab Clinic’s Swiss hub and the president of the Swiss Society ...
For 2026, the United Nations (UN) has chosen the theme “Rights. Justice. Action. For ALL Women and Girls.” The UN highlights the continuing inequalities faced by women and girls, noting: “Right now, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results